News

GJE Partner, Arnie Clarke, leads successful landmark opposition attack of Teva’s key 2030 patent (EP 2 949 335) on behalf of Mylan

Arnie Clarke has recently been involved in the ground-breaking appeal relating to Teva’s key 2030 patent (EP 2 949 335). Acting on behalf of Mylan, in front of the EPO board of appeal 3.3.04, Arnie obtained complete revocation of the patent covering the blockbuster Copaxone product, worth $1.51billion to Teva...

Read more

GJE recognised by Chambers & Partners 2021

We are pleased to be recognised as a leading firm in the 2021 edition of Chambers & Partners. Chambers identifies the best law firms globally through interviews and client feedback. The directory assesses client service, commercial vision and business understanding, along with diligence and value for money. GJE have been...

Read more

GJE noted as ‘one of the most trusted UK IP firms for patent prosecution and portfolio management work in Europe’ 2020

We are pleased to have been noted as ‘one of the most trusted UK IP firms for patent prosecution and portfolio management work in Europe’ and listed as a leading firm in the 2020 edition of Managing IP Stars. Every year, the publication independently researches practices in order to identify...

Read more

GJE recognised as a top firm in the Legal 500 2021

We are very pleased to be acknowledged by The Legal 500 as a top firm in the 2021 rankings. Legal 500 provide a worldwide review of the best and most recommended law firms and attorneys. The rankings are based on the practice area teams who provide cutting edge and innovative...

Read more

Oliver Henry James Beswetherick 1996 – 2020

Author: John Jappy, Partner         Oliver Henry James Beswetherick 1996 – 2020         It is with great sadness that we report the death of our trainee patent attorney, colleague and friend, Oliver Beswetherick, who died on 4 September 2020. Oliver, or Olly as he...

Read more